euromuscular functions in patients with the chronic fatigue syndrome versus patients with Fibromyalgia Syndrome and healthy people.

Completed

• Conditions: chronic fatigue syndrome; medically unexplained symptoms; 10028302; 10029317

• Registration Number: NL-OMON40416
• Lead Sponsor: Roessingh Research and Development

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 90

Inclusion Criteria

Group of Chronic Fatigue Syndrome (CVS-group): sufferers from chronic fatigue syndrome with the diagnosis confirmed by an interne physician.
Group of Fibromyalgia Syndrome (FMS-group): sufferers from (primary) fibromyalgia syndrome with the diagnosis confirmed by a rheumatologist.
Group of healthy people: healthy people that have explicitly no fatigue or pain.

Exclusion Criteria

Having co-existent diseases such as diabetes, circulatory and respiratory diseases, hepatic, renal and adrenal diseases, polyneuropathy and myopathy, obesity. Using medication such as tranquilizers, anti-epileptics and morphine. Alcohol and drugs abuses. Using a wheelchair, orthoses for back, neck and dominant arm.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Muscle conduction velocity</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Nerve conduction velocity; the number of *tender points*; items from the<br /><br>validated questionnaires. </p><br>